1. Home
  2. VRNA vs TFIN Comparison

VRNA vs TFIN Comparison

Compare VRNA & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • TFIN
  • Stock Information
  • Founded
  • VRNA 2005
  • TFIN 1981
  • Country
  • VRNA United Kingdom
  • TFIN United States
  • Employees
  • VRNA N/A
  • TFIN N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • TFIN Major Banks
  • Sector
  • VRNA Health Care
  • TFIN Finance
  • Exchange
  • VRNA Nasdaq
  • TFIN Nasdaq
  • Market Cap
  • VRNA 3.4B
  • TFIN 2.1B
  • IPO Year
  • VRNA 2017
  • TFIN N/A
  • Fundamental
  • Price
  • VRNA $48.33
  • TFIN $89.78
  • Analyst Decision
  • VRNA Strong Buy
  • TFIN Hold
  • Analyst Count
  • VRNA 6
  • TFIN 5
  • Target Price
  • VRNA $43.83
  • TFIN $71.80
  • AVG Volume (30 Days)
  • VRNA 854.0K
  • TFIN 117.0K
  • Earning Date
  • VRNA 02-27-2025
  • TFIN 01-21-2025
  • Dividend Yield
  • VRNA N/A
  • TFIN N/A
  • EPS Growth
  • VRNA N/A
  • TFIN N/A
  • EPS
  • VRNA N/A
  • TFIN 0.80
  • Revenue
  • VRNA $5,624,000.00
  • TFIN $398,012,000.00
  • Revenue This Year
  • VRNA N/A
  • TFIN N/A
  • Revenue Next Year
  • VRNA $644.06
  • TFIN $10.18
  • P/E Ratio
  • VRNA N/A
  • TFIN $113.76
  • Revenue Growth
  • VRNA 1127.95
  • TFIN N/A
  • 52 Week Low
  • VRNA $11.39
  • TFIN $66.85
  • 52 Week High
  • VRNA $47.29
  • TFIN $110.58
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 71.27
  • TFIN 37.67
  • Support Level
  • VRNA $45.05
  • TFIN $89.18
  • Resistance Level
  • VRNA $47.29
  • TFIN $92.19
  • Average True Range (ATR)
  • VRNA 2.21
  • TFIN 3.02
  • MACD
  • VRNA 0.45
  • TFIN -0.80
  • Stochastic Oscillator
  • VRNA 100.00
  • TFIN 16.69

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About TFIN Triumph Financial Inc.

Triumph Financial Inc is a is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Corporate. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The corporate segment includes holding company financing and investment activities and management and administrative expenses to support the overall operations of the Company.

Share on Social Networks: